Hsu et al., Structural features of human monoamine oxidase A elucidated from cDNA and peptide sequences. Journal of Neurochemistry, 51, 1321-1324, 1988.* |
Ablin, R., “A retrospective and prospective overview of prostate-specific antigen” J. of Cancer Res. and Clinical Oncology 123(11/12):583-594, 1997. |
Carducci et al., “Prostate-Specific Antigen and Other Markers of Therapeutic Response” Urologic Clinics of North America 26(2):291-301, 1999. |
Daher et al., “Prostate-Specific Antigen and New Related Markers for Prostate Cancer” Clin. Chem. Lab Med. 36(9):671-681, 1998. |
Keesee et al., “Utilization of Nuclear Matrix Proteins for Cancer Diagnosis” Critical Rev. in Eukaryotic Gene Expression 6(2-3):189-214, 1996. |
Moul, J. “Angiogenesis, p53, bcl02 and Ki-67 in the Progression of Prostate Cancer after Radical Prostatectomy” European Eurology 35:399-407, 1999. |
Ross, et al., “Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility” Cancer Research 58:4497-4504, 1998. |
Schalken, J., “Molecular Diagnostics and Therapy of Prostate Cancer: New Avenues” European Urology 34(3):3-6, 1998. |
Smith et al., “Future Directions in Tumor Marker Technology for Prostate Cancer” Urologic Clinics of North America 20(4):771-777, 1993. |
Young, et al., “Prostate-Specific Human Kallikrein (hK2) as a Novel Marker for Prostate Cancer” The Prostate Supplement 7:17-24, 1996. |